Skip to main content
Log in

Methylnaltrexon en obstipatie

  • Cats
  • Published:
Huisarts en wetenschap Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatuur

  1. Vereniging Integrale Kankercentra. Landelijke richtlijn Obstipatie, versie 2.0. 2009.www.oncoline.nl/richtlijn/doc/download.php?id=65.

  2. Candy B, Jones L, Goodman ML, Drake R, Tookman A. Laxatives or methylnaltrexone for the management of constipation in palliative care patients. Cochrane Database Syst Rev 2011 Jan 19;(1):CD003448.

  3. Clemens KE, Klaschik E. Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide. Ther Clin Risk Manag 2010;6:77–82.

    Article  PubMed  CAS  Google Scholar 

  4. De Groot JW, Peters FT, Reyners AK. De behandeling van obstipatie in de palliatieve fase. NTvG 2010;154:A2224.

    Google Scholar 

  5. Michna E, Blonsky ER, Schulman S, Tzanis E, Manley A, Zhang H, et al. Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study. J Pain 2011;May;12(5):554–62.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

huisarts (destijds aois huisartsgeneeskunde)

huisarts-epidemioloog

CATS, critically appraised topics, proberen een evidence-based antwoord op een praktijkvraag te krijgen. De coördinatie van deze rubriek is in handen van dr. A. Knuistingh Neven en dr. J.A.H. Eekhof, LUMC. Correspondentie:http://A.Knuistingh_Neven@lumc.nl

About this article

Cite this article

Baraya, M., Neven, A.K. Methylnaltrexon en obstipatie. HUISARTS WETENSCHAP 54, 628 (2011). https://doi.org/10.1007/s12445-011-0306-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12445-011-0306-6

Navigation